HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.18
Day range
$1.15 - $1.20
Year range
$0.59 - $11.12
Market cap
84.81M USD
Avg Volume
731.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.40M | -5.14% |
Operating expense | 6.84M | -22.14% |
Net income | -16.94M | 39.84% |
Net profit margin | -706.46 | 36.58% |
Earnings per share | -0.24 | 42.86% |
EBITDA | -15.99M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 128.17M | -24.96% |
Total assets | 174.06M | -24.22% |
Total liabilities | 32.05M | -39.41% |
Total equity | 142.01M | — |
Shares outstanding | 71.26M | — |
Price to book | 0.59 | — |
Return on assets | -21.71% | — |
Return on capital | -26.34% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -16.94M | 39.84% |
Cash from operations | -20.82M | 21.01% |
Cash from investing | 16.83M | -34.75% |
Cash from financing | -55.00K | — |
Net change in cash | -4.04M | -627.39% |
Free cash flow | -16.26M | -2.07% |
About
Founded
2012
Website
Employees
89